Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors1

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Immunology

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.178.7.4169PMID 17371973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.

  2006cited by this paper
• Induction of central T cell tolerance: Recombinant antibodies deliver peptides for deletion of antigen‐specific CD4+8+ thymocytes

  2005cited by this paper
• Primary antitumor immune response mediated by CD4+ T cells.

  2005cited by this paper
• In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination

  2004cited by this paper
• Monoclonal antibodies produced by muscle after plasmid injection and electroporation.

  2004cited by this paper
• CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

  2003cited by this paper
• DNA transfection of mononuclear cells in muscle tissue

  2003cited by this paper
• Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation.

  2002cited by this paper
• Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance

  2002cited by this paper
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance

  2002cited by this paper
• Efficient Delivery of T Cell Epitopes to APC by Use of MHC Class II-Specific Troybodies1

  2002cited by this paper
• Immunization with a Recombinant Adenovirus Encoding a Lymphoma Idiotype: Induction of Tumor-Protective Immunity and Identification of an Idiotype-Specific T Cell Epitope1

  2002cited by this paper
• A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation.

  2002cited by this paper
• Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus.

  2001cited by this paper
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001influential reference
• The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: Implications for peptide vaccination

  2001cited by this paper
• Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells

  1999cited by this paper
• Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

  1999cited by this paper
• CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

  1999cited by this paper
• Regulation of the size and distribution of agrin-induced postsynaptic-like apparatus in adult skeletal muscle by electrical muscle activity.

  1999cited by this paper
• CD40 and CD154 in cell-mediated immunity.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• Help for cytotoxic-T-cell responses is mediated by CD40 signalling

  1998cited by this paper
• Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells.

  1997cited by this paper
• Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

  1996cited by this paper
• The SCID but Not the RAG-2 Gene Product Is Required for Sμ–Sε Heavy Chain Class Switching

  1996influential reference
• The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing

  1995cited by this paper
• Naive CD4+ T cells confer idiotype‐specific tumor resistance in the absence of antibodies

  1995cited by this paper
• Modulation of cytokine expression in mouse dendritic cell clones

  1994cited by this paper
• Weak positive selection of transgenic T cell receptor‐bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities

  1992cited by this paper
• Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule.

  1989cited by this paper
• Idiotope‐specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules

  1986cited by this paper
• Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

  1983cited by this paper
• Establishment and characterization of BALB/c lymphoma lines with B cell properties.

  1979cited by this paper
• Myeloma proteins as tumor-specific transplantation antigens.

  1972cited by this paper

• A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine.

  2026cites this paper
• Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform

  2025cites this paper
• CD40 agonistic-monovalent streptavidin fusion antibody for targeted neoantigen peptide delivery and potent cancer vaccination

  2025cites this paper
• Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors

  2023cites this paper
• Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma: H chain-loss escapees cause FLC MM

  2023cites this paper
• Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine

  2023cites this paper
• STxB as an Antigen Delivery Tool for Mucosal Vaccination

  2022cites this paper
• Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses.

  2022cites this paper
• Nanomaterials‐Mediated Co‐Stimulation of Toll‐Like Receptors and CD40 for Antitumor Immunity

  2022cites this paper
• Antibody-mediated delivery of T-cell epitopes to antigen-presenting cells induce strong CD4 and CD8 T-cell responses.

  2021cites this paper
• CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model

  2020cites this paper
• A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza

  2020cites this paper
• Silica-Based Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy

  2020cites this paper
• Reverse immune suppressive microenvironment in tumor draining lymph nodes to enhance anti-PD1 immunotherapy via nanovaccine complexed microneedle

  2020cites this paper
• Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines

  2018cites this paper
• The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface Molecules

  2018cites this paper
• TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs

  2018cites this paper
• Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses

  2017cites this paper
• Targeting Influenza Virus Hemagglutinin to Xcr1+ Dendritic Cells in the Absence of Receptor-Mediated Endocytosis Enhances Protective Antibody Responses

  2017cites this paper
• Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination

  2016cites this paper
• Polymer-Based DNA Delivery Systems for Cancer Immunotherapy

  2016cites this paper
• Ribavirin stimulates the immune response of Atlantic salmon.

  2015cites this paper
• CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.

  2015cites this paper
• Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules

  2015cites this paper
• Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines

  2015cites this paper
• A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40

  2015cites this paper
• Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage.

  2015cites this paper
• Concept of Reverse Costimulation and Its Role in Diseases

  2015cites this paper
• Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsules.

  2014cites this paper
• Cellular immunotherapy in multiple myeloma: lessons from preclinical models.

  2014cites this paper
• Increased Generation of HIV-1 gp120-Reactive CD8+ T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3

  2014cites this paper
• Targeting human dendritic cells in situ to improve vaccines.

  2014cites this paper
• Dendritic Cell-Targeted Vaccines

  2014cites this paper
• DNA Vaccines: MHC II-Targeted Vaccine Protein Produced by Transfected Muscle Fibres Induces a Local Inflammatory Cell Infiltrate in Mice

  2014cites this paper
• Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice

  2014cites this paper
• InfluenzaAntibody-Mediated Protection against MHC Class II Molecules Rapidly Induces DNA Vaccine that Targets Hemagglutinin to

  2013cites this paper
• Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells

  2013cites this paper
• Antigen targeting to APC: from mice to veterinary species.

  2013cites this paper
• The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype

  2013cites this paper
• Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells

  2012cites this paper
• CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses.

  2012cites this paper
• Novel immunization strategies and interethnic differences in response to malaria infection

  2012cites this paper
• Heterodimeric Barnase-Barstar Vaccine Molecules: Influence of One versus Two Targeting Units Specific for Antigen Presenting Cells

  2012influential citation
• Generation of Antibody-Producing Hybridomas Following One Single Immunization with a Targeted DNA Vaccine

  2012cites this paper
• CD40‐targeted adenoviral cancer vaccines: the long and winding road to the clinic

  2012cites this paper
• REGULATION OF DENDRITIC CELL DIFFERENTIATION, MATURATION AND ACTIVATION

  2012cites this paper
• A novel chimeric DNA vaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by fusion of Mucin 1 to a heat shock protein 70 gene.

  2011cites this paper
• Targeted idiotype‐fusion DNA vaccines for human multiple myeloma: preclinical testing

  2011cites this paper
• Antigen cross‐presentation: extending recent laboratory findings to therapeutic intervention

  2011cites this paper
• Optimizing Therapeutic Antibody Function

  2011cites this paper
• Approaches to improved targeting of DNA vaccines

  2011cites this paper
• Harnessing dendritic cells for immunotherapy.

  2011cites this paper
• Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines.

  2010cites this paper
• Antibodies in single-chain format against tumour-associated antigens: present and future applications.

  2010cites this paper
• Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

  2010cites this paper
• Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model.

  2010cites this paper
• Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.

  2009cites this paper
• Dendritic cells and their receptors in antitumor immune response.

  2009cites this paper
• Targeting CD40 in Waldenström's macroglobulinemia.

  2009cites this paper
• A novel mutation in CD40 and its functional characterization

  2009cites this paper
• Recombinant antibodies for delivery of antigen: a single loop between beta-strands in the constant region can accommodate long, complex and tandem T cell epitopes.

  2008cites this paper
• Processing of an Antigenic Sequence from IgG Constant Domains for Presentation by MHC Class II1

  2008cites this paper
• Boosting Anti‐idiotype Immune Response with Recombinant AAV Enhances Tumour Protection Induced by Gene Gun Vaccination

  2008cites this paper
• Class II IgG Constant Domains for Presentation by Processing of an Antigenic Sequence from and

  2008cites this paper
• A functional TNFRSF5 gene variant is associated with risk of lymphoma.

  2008cites this paper
• Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells

  2007cites this paper
• Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences.

  2007cites this paper
• Dendritic cell subsets in health and disease

  2007influential citation
• Hideki Ueno Eynav Klechevsky Rimpei Morita Caroline Aspord Tinghua Cao Toshimichi Matsui Tiziana Di Pucchio John Connolly

  2007influential citation
• Taking dendritic cells into medicine

  2007cites this paper
• Electrotransfer of therapeutic molecules into tissues.

  2007cites this paper
• Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer

  2006cites this paper